|
WO2016176692A2
|
|
Biosensor chip
|
|
US2016178562A1
|
|
Competitive enzymatic assay
|
|
WO2016049240A1
|
|
Prostate specific antigen proteolytic activity for clinical use
|
|
US2016041118A1
|
|
Enzyme triggered redox altering chemical elimination (e-trace) assay with multiplexing capabilities
|
|
CN106662583A
|
|
Bioelectronic binding assay using peak profiling
|
|
EP3047274A2
|
|
Psa enzymatic activity: a new biomarker for assessing prostate cancer aggressiveness
|
|
WO2014018886A1
|
|
Electronic measurements of monolayers following homogeneous reactions of their components
|
|
CA2880104A1
|
|
Electric measurement of monolayers following pro-cleave detection of presence and activity of enzymes and other target analytes
|
|
WO2013106434A1
|
|
Enzyme cascade methods for e-trace assay signal amplification
|
|
CA2854459A1
|
|
Novel chemistry used in biosensors
|
|
CA2851632A1
|
|
Single, direct detection of hemoglobin a1c percentage using enzyme triggered redox altering chemical elimination (e-trace) immunoassay
|
|
WO2012100078A1
|
|
Enzyme triggered redox altering chemical elimination (e-trace) immmunoassay
|
|
WO2012012537A1
|
|
Novel chemistry used in biosensors
|
|
WO2011146143A2
|
|
Enzymatic activity of psa as diagnostic marker for prostate cancer
|
|
EP2642291A1
|
|
Enzyme triggered redox altering chemical elimination (E-trace) immunoassay
|
|
EP2210268A1
|
|
Novel chemistry used in biosensors
|
